Isabel Aznarez
Founder at STOKE THERAPEUTICS, INC.
Profile
Isabel Aznarez is the founder of Stoke Therapeutics, Inc. which was founded in 2014.
She holds the title of Senior Vice President-Discovery Research at Stoke Therapeutics, Inc. Dr. Aznarez's current job is as a Director at Oligonucleotide Therapeutics Society, Inc. since 2019.
Dr. Aznarez obtained a doctorate degree from the University of Toronto in 2006 and also has an undergraduate degree from Universidad De La Republica Uruguay.
Isabel Aznarez active positions
Companies | Position | Start |
---|---|---|
STOKE THERAPEUTICS, INC. | Founder | 2014-05-31 |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Director/Board Member | 2018-12-31 |
Training of Isabel Aznarez
University of Toronto | Doctorate Degree |
Universidad De La Republica Uruguay | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
STOKE THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
- Stock Market
- Insiders
- Isabel Aznarez